When it comes to improving libido, the best advice — the advice that is truly evidence-based — tends to be rather unsexy: Get ...
On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback